Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Tumor necrosis factor-alpha blockade and the risk of vasculitis.

× No keyword cloud information.

15 in total

Review 1. Giant cell arteritis, polymyalgia rheumatica, and late-onset rheumatoid arthritis: Can they be components of a single disease process in elderly patients?

Authors: Cengiz Korkmaz; Pınar Yıldız
Journal: Eur J Rheumatol Date: 2017-02-24

2. A 5-year Retrospective Analysis of Drug Survival, Safety, and Effectiveness of the Infliximab Biosimilar CT-P13 in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis.

Authors: Tae-Hwan Kim; Shin-Seok Lee; Won Park; Yeong Wook Song; Chang-Hee Suh; SooKyoung Kim; Young Nam Lee; Dae Hyun Yoo
Journal: Clin Drug Investig Date: 2020-06 Impact factor: 2.859

Review 3. Polyarteritis nodosa revisited.

Authors: Inés Colmegna; José A Maldonado-Cocco
Journal: Curr Rheumatol Rep Date: 2005-08 Impact factor: 4.592

Review 4. Adverse reactions to biologic agents and their medical management.

Authors: Onur Boyman; Denis Comte; François Spertini
Journal: Nat Rev Rheumatol Date: 2014-08-12 Impact factor: 20.543

5. Lymphoedema: a paradoxical effect of tumour necrosis factor inhibitors - case report and review of literature.

Authors: Hajra Ismail Tily; Andras Perl
Journal: BMJ Case Rep Date: 2009-03-05

6. Severe Henoch-Schönlein purpura with infliximab for ulcerative colitis.

Authors: Yang Song; Yan-Hong Shi; Chong He; Chang-Qin Liu; Jun-Shan Wang; Yu-Jie Zhao; Yan-Min Guo; Rui-Jin Wu; Xiao-Yue Feng; Zhan-Ju Liu
Journal: World J Gastroenterol Date: 2015-05-21 Impact factor: 5.742

Review 7. Indications for biotherapy in systemic vasculitides.

Authors: Loïc Guillevin; Christian Pagnoux; Philippe Guilpain; Boris Bienvenu; Valérie Martinez; Luc Mouthon
Journal: Clin Rev Allergy Immunol Date: 2007-02 Impact factor: 10.817

8. Appearance of ANCA - associated vasculitis under Tumor necrosis factor-alpha inhibitors treatment.

Authors: Tatiana Reitblat; Olga Reitblat
Journal: Am J Case Rep Date: 2013-03-20

9. Permanent renal loss following tumor necrosis factor α antagonists for arthritis.

Authors: Tzu-Jen Chen; Ya-Fei Yang; Po-Hao Huang; Hsin-Hung Lin; Chiu-Ching Huang
Journal: Rheumatol Int Date: 2009-06-18 Impact factor: 3.580

10. Adalimumab (TNF α Inhibitor) Therapy Exacerbates IgA Glomerulonephritis Acute Renal Injury and Induces Lupus Autoantibodies in a Psoriasis Patient.

Authors: S S Wei; R Sinniah
Journal: Case Rep Nephrol Date: 2013-07-24